Is global elimination of HCV realistic?-Reference-Cited by-同舟云学术

Is global elimination of HCV realistic?

Published:2018-02 Issue: Volume:38 Page:40-46
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Calvaruso Vincenza¹^ORCID,Petta Salvatore¹^ORCID,Craxì Antonio¹

Affiliation:

1. Sezione di Gastroenterologia & Epatologia; DIBIMIS; Università di Palermo; Palermo Italy

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13668/fullpdf

Reference66 articles.

1. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review;Falade-Nwulia;Ann Intern Med,2017

2. ASTRAL-2 Investigators; ASTRAL-3 Investigators. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection;Foster;N Engl J Med,2015

3. ASTRAL-1 Investigators. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection;Feld;N Engl J Med,2015

4. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis;Curry;N Engl J Med,2015

5. Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients with HCV Genotype 2, 4, 5, or 6 Infection Without Cirrhosis;Asselah;Clin Gastroenterol Hepatol,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review;Canadian Journal of Gastroenterology and Hepatology;2024-03-07

2. Global Epidemiology and Genetics of Hepatocellular Carcinoma;Gastroenterology;2023-04

3. Therapeutic innovation in high-prevalence chronic diseases: Challenges and opportunities for specialist care models;Health Services Management Research;2022-11-04

4. The Lived Experience of Patients Utilizing Second-Generation Direct-Acting Antiviral for Treatment of Chronic Hepatitis C Virus Infection: A Phenomenological Analysis;International Journal of Environmental Research and Public Health;2022-10-01

5. Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir;Biochemistry and Biophysics Reports;2022-07